TY  - JOUR
AU  - Entrenas Castillo, Marta
AU  - Entrenas Costa, Luis Manuel
AU  - Vaquero Barrios, Jose Manuel
AU  - Alcala Diaz, Juan Francisco
AU  - Lopez Miranda, Jose
AU  - Bouillon, Roger
AU  - Quesada Gomez, Jose Manuel
PY  - 2020
DO  - 10.1016/j.jsbmb.2020.105751
UR  - http://hdl.handle.net/10668/16186
T2  - The Journal of steroid biochemistry and molecular biology
AB  - The vitamin D endocrine system may have a variety of actions on cells and tissues involved in COVID-19 progression especially by decreasing the Acute Respiratory Distress Syndrome. Calcifediol can rapidly increase serum 25OHD concentration. We...
LA  - en
KW  - 1α, 25(OH)2D or 1α, 25-dihydroxyvitamin D or calcitriol
KW  - Acute respiratory distress syndrome (ARDS)
KW  - COVID-19
KW  - Calcifediol or 25-hydroxyvitamin D3
KW  - Cathelicidin peptide
KW  - Chloroquine
KW  - Covidiol
KW  - Cuboidal alveolar coating cells type II
KW  - Cytokine/Chemokine storm
KW  - Defensins
KW  - Hydroxychloroquine
KW  - Hypercoagulability
KW  - Neutrophil activity
KW  - Renin-angiotensin system
KW  - SARS-CoV-2
KW  - TLR co-receptor CD14
KW  - Vitamin D
KW  - Vitamin D endocrine system
KW  - Vitamin D receptor
KW  - Vitamin D3 or cholecalciferol
KW  - Betacoronavirus
KW  - Bone density conservation agents
KW  - COVID-19
KW  - Calcifediol
KW  - Coronavirus infections
KW  - Double-blind method
KW  - Female
KW  - Hospitalization
KW  - Humans
KW  - Intensive care units
KW  - Male
KW  - Middle aged
KW  - Pandemics
KW  - Pilot projects
KW  - Pneumonia, viral
KW  - Prognosis
KW  - SARS-CoV-2
TI  - "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
TY  - research article
VL  - 203
ER  -